On Monday, EyePoint Pharmaceuticals Inc. EYPT announced the topline results of its Phase 2 PAVIA trial evaluating Duravyu (vorolanib intravitreal insert),…
Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) gapped down before the market opened on Monday . The stock had previously closed at $19.74, but opened at $13.89. EyePoint Pharmaceuticals shares last traded at $12.99, with a volume of 4,364,816 shares traded. Analyst Upgrades and Downgrades A number of equities research analysts have […]